随着中国经济水平的提高,人口老龄化的日益突出,以及国家对医疗器械行业政策的调整,中国骨科植入物市场正在快速地发展。本报告基于对国内外骨科植入物行业的调研,统计2015年至2018年间持有第二、三类骨科植入物产品注册证的国内和国外生产企业注册证获批情况。市场方面,对比2017年和2018年国产及进口创伤、脊柱、关节三大领域市场份额,人工关节植入物市场销售收入增长率远高于创伤、脊柱植入物市场;创伤植入物国产化效果显著。调研结果显示,国内骨科植入物市场的渗透率不足5%,远低于美国的40%~70%。医工结合、终端降价、合规经营是骨科植入物市场发展过程中遇到的热点问题。
<<With the improvement of China’s economic level,the increasingly prominent aging of the population,and the adjustment of the national policy on the orthopaedic implant industry,China’s orthopaedic market is developing healthily and rapidly. Based on the in-depth investigation of the orthopaedic implant industry at home and abroad,this report provides statistics on the regional distribution and approval of domestic and foreign enterprises holding the second and third types of orthopaedic implant product registration certificates between 2015 and 2018. In the aspect of market,comparing the market share of domestic and foreign trauma,spine and joint in 2017 and 2018,the growth rate of joint market was much higher than that of trauma and spine market,and the domestic market share of trauma was the most significant. In addition,through the investigation of the global orthopaedic market in the past five years,it is found that the penetration rate of each segment of orthopaedic implants in China is less than 5%,which is much lower than that of 40%-70% in the United States. The following hot issues,such as the combination of medical and industrial,terminal price reduction,compliance management,are the focus of orthopaedic implant production enterprises in the future.
<<